Can zonisamide cause bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Zonisamide Cause Bradycardia?

Yes, zonisamide can cause bradycardia, though this is a rare but documented adverse effect that occurred in at least one severe overdose case requiring hospitalization.

Evidence from FDA Drug Labeling

The FDA prescribing information for zonisamide explicitly documents bradycardia as a cardiovascular manifestation in overdose situations. In one documented case, a patient who ingested an unknown amount of zonisamide as a suicide attempt developed bradycardia along with hypotension and respiratory depression 1. This patient became comatose with a zonisamide plasma level of 100.1 mcg/mL measured 31 hours post-ingestion, and required five days to become alert 1.

Absence in Standard Adverse Event Profiles

Importantly, bradycardia is not listed among the common or even uncommon adverse events in therapeutic dosing scenarios. The FDA labeling identifies the most common adverse events as fatigue, dizziness, somnolence, anorexia, and abnormal thinking 1. The comprehensive guideline review from the American Academy of Neurology and American Epilepsy Society similarly does not mention bradycardia among adverse events in clinical trials 2.

The pediatric safety analysis of 398 patients (mean exposure 318.7 days) reported no cardiovascular adverse events or clinically significant ECG abnormalities with zonisamide treatment 3.

Clinical Context and Mechanism

The FDA labeling notes that zonisamide can cause "changes in heartbeat" as a potential manifestation of metabolic acidosis 1. However, the specific bradycardic effect appears to be:

  • Dose-dependent: Only documented in severe overdose
  • Part of systemic toxicity: Occurred alongside CNS depression, hypotension, and respiratory compromise
  • Not a therapeutic-dose concern: Absent from controlled trials and large safety databases

Practical Recommendations

Monitor for bradycardia only in overdose situations or when zonisamide is combined with other medications known to cause bradycardia. In therapeutic dosing:

  • Routine cardiac monitoring is not indicated based on available evidence
  • Focus monitoring on the well-established adverse effects: metabolic acidosis (check bicarbonate levels), kidney stones, decreased sweating/hyperthermia, and cognitive effects 1
  • If bradycardia develops during therapeutic use, investigate other causes first (drug interactions, underlying cardiac disease, electrolyte abnormalities)

In overdose scenarios, expect potential bradycardia as part of the toxidrome and prepare for supportive care including possible vasopressor support, as demonstrated in the documented case 1.

Related Questions

Does clonazepam (Klonopin) cause bradycardia, and what is the recommended management if a patient on clonazepam develops a heart rate below 60 beats per minute?
What is the appropriate outpatient evaluation and management plan for a 32-year-old woman with no past medical history who experiences episodes of sinus bradycardia with heart rates in the 30s?
Should a 63-year-old man with sinus bradycardia on electrocardiogram be referred to cardiology?
For a patient with symptomatic sinus bradycardia, after ruling out all reversible causes, whose symptoms limit his ability to work as a carpenter and who has been on work restrictions for a month, what is the recommended definitive therapy?
What is the best management approach for an apparently healthy young adult male with asymptomatic sinus bradycardia (heart rate 47 beats per minute)?
What serum cortisol level indicates the need for a short Synacthen (ACTH stimulation) test?
What is the definition of blast crisis in chronic myeloid leukemia?
What is the recommended management for a stable immunocompromised patient with a positive MRSA nasal PCR after completing therapy for pneumonia?
What is the appropriate management for a patient with left upper extremity strength 2‑/5 due to pain, who cannot achieve full range of motion or lift a 5‑lb dumbbell?
Is cannabis‑induced psychosis typically transient?
How should the Model for End‑Stage Liver Disease (MELD) score be applied in the inpatient management of adults with chronic liver disease or acute decompensation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.